Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis B, Chronic | 3 | 2021 | 616 | 1.61 | Why? |
| Hepatitis B | 2 | 2021 | 888 | 1.00 | Why? |
| Jaundice | 1 | 2021 | 114 | 0.79 | Why? |
| Baculoviridae | 1 | 2019 | 132 | 0.77 | Why? |
| Anastomotic Leak | 1 | 2018 | 46 | 0.71 | Why? |
| Mucin-1 | 1 | 2021 | 277 | 0.70 | Why? |
| Spores, Bacterial | 1 | 2017 | 45 | 0.67 | Why? |
| Angiography | 1 | 2018 | 301 | 0.67 | Why? |
| Anastomosis, Surgical | 1 | 2018 | 169 | 0.66 | Why? |
| Automobile Driving | 1 | 2018 | 222 | 0.57 | Why? |
| Rectal Neoplasms | 1 | 2018 | 278 | 0.51 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.51 | Why? |
| Water | 1 | 2017 | 765 | 0.47 | Why? |
| Genetic Vectors | 1 | 2019 | 1600 | 0.46 | Why? |
| Transportation | 1 | 2018 | 691 | 0.46 | Why? |
| Lung Injury | 1 | 2021 | 919 | 0.45 | Why? |
| Hepatitis B virus | 3 | 2021 | 882 | 0.39 | Why? |
| Lycium | 2 | 2019 | 20 | 0.39 | Why? |
| Radiography, Dual-Energy Scanned Projection | 2 | 2019 | 53 | 0.38 | Why? |
| Biosynthetic Pathways | 2 | 2019 | 97 | 0.36 | Why? |
| Buffaloes | 2 | 2018 | 56 | 0.35 | Why? |
| Polymers | 3 | 2019 | 507 | 0.30 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.28 | Why? |
| Algorithms | 2 | 2019 | 7346 | 0.23 | Why? |
| DNA | 2 | 2019 | 778 | 0.21 | Why? |
| Lovastatin | 1 | 2019 | 11 | 0.21 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.20 | Why? |
| Coreopsis | 1 | 2019 | 1 | 0.20 | Why? |
| Ectromelia | 1 | 2019 | 1 | 0.20 | Why? |
| Bone Lengthening | 1 | 2019 | 2 | 0.20 | Why? |
| Leg Length Inequality | 1 | 2019 | 3 | 0.20 | Why? |
| Metabolic Engineering | 1 | 2019 | 41 | 0.20 | Why? |
| Tumor Hypoxia | 1 | 2018 | 9 | 0.20 | Why? |
| Fluorine | 1 | 2018 | 7 | 0.20 | Why? |
| Polyamines | 1 | 2019 | 44 | 0.20 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.19 | Why? |
| Spodoptera | 1 | 2019 | 220 | 0.19 | Why? |
| Cloning, Organism | 1 | 2018 | 21 | 0.19 | Why? |
| Sf9 Cells | 1 | 2019 | 273 | 0.19 | Why? |
| Anthocyanins | 1 | 2019 | 51 | 0.19 | Why? |
| Tibia | 1 | 2019 | 72 | 0.18 | Why? |
| Embryonic Development | 1 | 2018 | 55 | 0.18 | Why? |
| Receptor, Angiotensin, Type 2 | 1 | 2020 | 190 | 0.18 | Why? |
| Sorghum | 1 | 2017 | 6 | 0.18 | Why? |
| Porphyrins | 1 | 2018 | 88 | 0.18 | Why? |
| Animal Feed | 1 | 2018 | 72 | 0.18 | Why? |
| Lignin | 1 | 2017 | 14 | 0.18 | Why? |
| Dendrimers | 1 | 2019 | 104 | 0.18 | Why? |
| Receptors, CCR5 | 1 | 2019 | 186 | 0.17 | Why? |
| Fracture Healing | 1 | 2017 | 37 | 0.17 | Why? |
| Radiologic and Imaging Nursing | 1 | 2016 | 9 | 0.17 | Why? |
| Mammary Glands, Human | 1 | 2017 | 23 | 0.17 | Why? |
| Neoplasms, Experimental | 1 | 2017 | 67 | 0.17 | Why? |
| Lumbar Vertebrae | 1 | 2019 | 196 | 0.17 | Why? |
| Chemoembolization, Therapeutic | 1 | 2018 | 144 | 0.17 | Why? |
| Memory Disorders | 1 | 2019 | 190 | 0.17 | Why? |
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 67 | 0.17 | Why? |
| Artifacts | 1 | 2019 | 250 | 0.17 | Why? |
| Saccharomyces cerevisiae | 1 | 2019 | 339 | 0.17 | Why? |
| Osteomyelitis | 1 | 2019 | 131 | 0.16 | Why? |
| Functional Food | 1 | 2018 | 122 | 0.16 | Why? |
| Cannabinoids | 1 | 2019 | 134 | 0.16 | Why? |
| Bacterial Load | 1 | 2017 | 179 | 0.16 | Why? |
| Cellular Reprogramming | 1 | 2017 | 117 | 0.16 | Why? |
| Oleanolic Acid | 1 | 2017 | 82 | 0.16 | Why? |
| Hematopoietic Stem Cells | 1 | 2019 | 321 | 0.16 | Why? |
| Phenols | 1 | 2018 | 226 | 0.16 | Why? |
| Liver | 2 | 2021 | 4007 | 0.16 | Why? |
| Food Microbiology | 1 | 2017 | 114 | 0.16 | Why? |
| X-Rays | 1 | 2018 | 492 | 0.16 | Why? |
| Neuroprotective Agents | 1 | 2019 | 240 | 0.15 | Why? |
| Gene Editing | 1 | 2019 | 330 | 0.15 | Why? |
| Flavonoids | 2 | 2018 | 492 | 0.15 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 382 | 0.15 | Why? |
| Cellulases | 1 | 2014 | 1 | 0.15 | Why? |
| Tomography, X-Ray Computed | 5 | 2021 | 25144 | 0.15 | Why? |
| Diabetic Nephropathies | 1 | 2019 | 315 | 0.14 | Why? |
| Plant Proteins | 1 | 2017 | 194 | 0.14 | Why? |
| HIV-1 | 3 | 2019 | 3365 | 0.14 | Why? |
| Drug Carriers | 2 | 2018 | 590 | 0.14 | Why? |
| Oxidation-Reduction | 1 | 2017 | 540 | 0.14 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 869 | 0.14 | Why? |
| Culture Media | 1 | 2017 | 366 | 0.14 | Why? |
| Cannabis | 1 | 2019 | 284 | 0.14 | Why? |
| Histocompatibility Antigens Class I | 1 | 2019 | 624 | 0.14 | Why? |
| Neoadjuvant Therapy | 1 | 2018 | 554 | 0.14 | Why? |
| Acupuncture Therapy | 1 | 2018 | 234 | 0.14 | Why? |
| Aspartate Aminotransferases | 1 | 2021 | 1394 | 0.13 | Why? |
| Humans | 37 | 2021 | 930598 | 0.13 | Why? |
| Photochemotherapy | 1 | 2018 | 297 | 0.13 | Why? |
| Signal-To-Noise Ratio | 3 | 2019 | 217 | 0.13 | Why? |
| Plant Extracts | 3 | 2019 | 1514 | 0.13 | Why? |
| Abdomen | 1 | 2016 | 424 | 0.13 | Why? |
| Mice, Nude | 3 | 2018 | 340 | 0.12 | Why? |
| Pancreatitis | 1 | 2021 | 688 | 0.12 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.12 | Why? |
| Mass Spectrometry | 2 | 2018 | 1165 | 0.12 | Why? |
| Deglutition Disorders | 1 | 2018 | 481 | 0.12 | Why? |
| Brain Injuries, Traumatic | 1 | 2017 | 381 | 0.12 | Why? |
| Ovarian Neoplasms | 1 | 2017 | 465 | 0.11 | Why? |
| User-Computer Interface | 1 | 2018 | 1068 | 0.11 | Why? |
| Program Development | 1 | 2018 | 1089 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.11 | Why? |
| Hong Kong | 1 | 2020 | 3361 | 0.11 | Why? |
| Biotechnology | 1 | 2014 | 444 | 0.11 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.11 | Why? |
| Diarrhea | 2 | 2020 | 2743 | 0.11 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.10 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.10 | Why? |
| CRISPR-Cas Systems | 1 | 2019 | 1397 | 0.10 | Why? |
| Virtual Reality | 1 | 2018 | 640 | 0.10 | Why? |
| Temperature | 2 | 2017 | 2305 | 0.10 | Why? |
| Swine | 1 | 2018 | 3352 | 0.10 | Why? |
| Recombinant Proteins | 1 | 2019 | 3786 | 0.09 | Why? |
| MicroRNAs | 2 | 2019 | 1787 | 0.09 | Why? |
| Galactose | 2 | 2019 | 201 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Oxidative Stress | 1 | 2019 | 2050 | 0.09 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| Biomass | 2 | 2017 | 80 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 2426 | 0.07 | Why? |
| Immunologic Memory | 1 | 2017 | 3362 | 0.07 | Why? |
| Liposomes | 2 | 2017 | 334 | 0.07 | Why? |
| Antineoplastic Agents | 2 | 2018 | 3550 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Animals | 9 | 2019 | 78931 | 0.07 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| HIV Infections | 2 | 2019 | 11620 | 0.06 | Why? |
| Antibodies, Viral | 3 | 2020 | 51949 | 0.06 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.06 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.06 | Why? |
| Mice, Inbred BALB C | 3 | 2018 | 5814 | 0.06 | Why? |
| Hydrogen-Ion Concentration | 2 | 2018 | 993 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Chromatography, High Pressure Liquid | 2 | 2018 | 669 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.06 | Why? |
| Plants, Edible | 1 | 2021 | 112 | 0.05 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.05 | Why? |
| HEK293 Cells | 3 | 2020 | 8394 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.05 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.05 | Why? |
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 30 | 0.05 | Why? |
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2019 | 8 | 0.05 | Why? |
| Acyl Coenzyme A | 1 | 2019 | 8 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.05 | Why? |
| Polyisoprenyl Phosphates | 1 | 2019 | 8 | 0.05 | Why? |
| Transcription Factor AP-1 | 1 | 2019 | 75 | 0.05 | Why? |
| Chlorophyllides | 1 | 2018 | 4 | 0.05 | Why? |
| Alkyl and Aryl Transferases | 1 | 2019 | 22 | 0.05 | Why? |
| Mice, Inbred NOD | 1 | 2019 | 134 | 0.05 | Why? |
| Gastrointestinal Contents | 1 | 2018 | 7 | 0.05 | Why? |
| Mevalonic Acid | 1 | 2019 | 24 | 0.05 | Why? |
| Nuclear Transfer Techniques | 1 | 2018 | 6 | 0.05 | Why? |
| PTEN Phosphohydrolase | 1 | 2019 | 70 | 0.05 | Why? |
| Salicylates | 1 | 2019 | 48 | 0.05 | Why? |
| Polyelectrolytes | 1 | 2019 | 47 | 0.05 | Why? |
| Convalescence | 2 | 2020 | 2829 | 0.05 | Why? |
| Coculture Techniques | 1 | 2019 | 258 | 0.05 | Why? |
| Weaning | 1 | 2018 | 46 | 0.05 | Why? |
| Cyclooxygenase 2 | 1 | 2019 | 129 | 0.05 | Why? |
| Micelles | 1 | 2018 | 96 | 0.05 | Why? |
| Spinal Fusion | 1 | 2019 | 76 | 0.05 | Why? |
| Protein Binding | 3 | 2021 | 11430 | 0.05 | Why? |
| Dronabinol | 1 | 2019 | 89 | 0.05 | Why? |
| Cecum | 1 | 2018 | 63 | 0.05 | Why? |
| Fermentation | 1 | 2019 | 156 | 0.05 | Why? |
| Fatty Acids, Volatile | 1 | 2018 | 63 | 0.05 | Why? |
| Drug Liberation | 1 | 2018 | 141 | 0.05 | Why? |
| Heterografts | 1 | 2018 | 203 | 0.05 | Why? |
| Adult | 7 | 2021 | 244371 | 0.05 | Why? |
| Benzoates | 1 | 2019 | 102 | 0.04 | Why? |
| Alcohols | 1 | 2019 | 86 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Cell Adhesion | 1 | 2019 | 230 | 0.04 | Why? |
| Organophosphorus Compounds | 1 | 2017 | 53 | 0.04 | Why? |
| Lasers | 1 | 2018 | 132 | 0.04 | Why? |
| CD4 Antigens | 1 | 2019 | 306 | 0.04 | Why? |
| Albuminuria | 1 | 2019 | 164 | 0.04 | Why? |
| Blastocyst | 1 | 2018 | 65 | 0.04 | Why? |
| Mammary Glands, Animal | 1 | 2017 | 9 | 0.04 | Why? |
| Chromones | 1 | 2017 | 42 | 0.04 | Why? |
| MCF-7 Cells | 1 | 2017 | 199 | 0.04 | Why? |
| Oocytes | 1 | 2018 | 86 | 0.04 | Why? |
| Wetlands | 1 | 2017 | 32 | 0.04 | Why? |
| Indocyanine Green | 1 | 2017 | 66 | 0.04 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Cells, Cultured | 2 | 2019 | 5835 | 0.04 | Why? |
| Publication Bias | 1 | 2018 | 241 | 0.04 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.04 | Why? |
| Luteolin | 1 | 2017 | 70 | 0.04 | Why? |
| Tissue Distribution | 1 | 2018 | 483 | 0.04 | Why? |
| Heterocyclic Compounds | 1 | 2017 | 64 | 0.04 | Why? |
| Osteogenesis | 1 | 2017 | 95 | 0.04 | Why? |
| Fruit | 1 | 2019 | 313 | 0.04 | Why? |
| Cellulose | 1 | 2017 | 106 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.04 | Why? |
| Cloning, Molecular | 1 | 2020 | 1036 | 0.04 | Why? |
| Theranostic Nanomedicine | 1 | 2017 | 143 | 0.04 | Why? |
| Infrared Rays | 1 | 2017 | 127 | 0.04 | Why? |
| Biocompatible Materials | 1 | 2019 | 214 | 0.04 | Why? |
| Ileum | 1 | 2018 | 233 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 372 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2020 | 25288 | 0.04 | Why? |
| Methylation | 1 | 2017 | 332 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Light | 1 | 2018 | 306 | 0.04 | Why? |
| Male | 8 | 2021 | 367725 | 0.04 | Why? |
| Photosensitizing Agents | 1 | 2018 | 279 | 0.04 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2019 | 987 | 0.04 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| Virus Latency | 1 | 2017 | 251 | 0.04 | Why? |
| Phototherapy | 1 | 2017 | 138 | 0.04 | Why? |
| Aged | 4 | 2021 | 215776 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Methanol | 1 | 2017 | 149 | 0.04 | Why? |
| Glucans | 1 | 2014 | 13 | 0.04 | Why? |
| Ionic Liquids | 1 | 2014 | 11 | 0.04 | Why? |
| Organometallic Compounds | 1 | 2017 | 206 | 0.04 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.04 | Why? |
| Hydrogen Bonding | 1 | 2017 | 599 | 0.04 | Why? |
| Radiation Dosage | 1 | 2019 | 585 | 0.03 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.03 | Why? |
| Hydrolysis | 1 | 2014 | 160 | 0.03 | Why? |
| CD4 Lymphocyte Count | 1 | 2019 | 1517 | 0.03 | Why? |
| Lactation | 1 | 2017 | 361 | 0.03 | Why? |
| Inhibitory Concentration 50 | 1 | 2017 | 907 | 0.03 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 526 | 0.03 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.03 | Why? |
| Blood Cell Count | 1 | 2019 | 1101 | 0.03 | Why? |
| Interleukin-1beta | 1 | 2019 | 992 | 0.03 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 552 | 0.03 | Why? |
| Down-Regulation | 1 | 2019 | 1416 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Substrate Specificity | 1 | 2014 | 639 | 0.03 | Why? |
| Brain Injuries | 1 | 2017 | 374 | 0.03 | Why? |
| Viral Matrix Proteins | 1 | 2020 | 1243 | 0.03 | Why? |
| Neoplasms | 2 | 2017 | 17251 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| NF-kappa B | 1 | 2019 | 1301 | 0.03 | Why? |
| Rats | 1 | 2019 | 2764 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2019 | 1316 | 0.03 | Why? |
| Anti-Retroviral Agents | 1 | 2019 | 1099 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Membrane Proteins | 1 | 2019 | 1733 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Imidazoles | 1 | 2014 | 631 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Environmental Monitoring | 1 | 2021 | 3143 | 0.02 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.02 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Lymphocyte Activation | 1 | 2017 | 2742 | 0.02 | Why? |
| Nanostructures | 1 | 2014 | 700 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2019 | 4020 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Diet | 1 | 2018 | 2052 | 0.02 | Why? |
| High-Throughput Screening Assays | 1 | 2014 | 1783 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Blood Glucose | 1 | 2019 | 3642 | 0.02 | Why? |
| Pilot Projects | 1 | 2016 | 5182 | 0.02 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.02 | Why? |
| Workflow | 1 | 2014 | 2373 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Research | 1 | 2017 | 2115 | 0.02 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2019 | 6670 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Molecular Docking Simulation | 1 | 2017 | 6902 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2019 | 10998 | 0.01 | Why? |
| Mice | 1 | 2019 | 21357 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.01 | Why? |
Deng's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(306)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(117)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_